Financhill
Sell
49

OVV Quote, Financials, Valuation and Earnings

Last price:
$38.05
Seasonality move :
2.59%
Day range:
$37.64 - $38.31
52-week range:
$29.80 - $46.35
Dividend yield:
3.16%
P/E ratio:
41.66x
P/S ratio:
1.11x
P/B ratio:
0.94x
Volume:
3.4M
Avg. volume:
3.2M
1-year change:
-1.83%
Market cap:
$9.6B
Revenue:
$9B
EPS (TTM):
$0.91

Analysts' Opinion

  • Consensus Rating
    Ovintiv, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $53.89, Ovintiv, Inc. has an estimated upside of 41.75% from its current price of $38.05.
  • Price Target Downside
    According to analysts, the lowest downside price target is $42.00 representing -10.47% downside risk from its current price of $38.05.

Fair Value

  • According to the consensus of 17 analysts, Ovintiv, Inc. has 41.75% upside to fair value with a price target of $53.89 per share.

OVV vs. S&P 500

  • Over the past 5 trading days, Ovintiv, Inc. has underperformed the S&P 500 by -0.01% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Ovintiv, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Ovintiv, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ovintiv, Inc. reported revenues of $2B.

Earnings Growth

  • Ovintiv, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Ovintiv, Inc. reported earnings per share of $0.57.
Enterprise value:
16B
EV / Invested capital:
0.96x
Price / LTM sales:
1.11x
EV / EBIT:
8.27x
EV / Revenue:
1.81x
PEG ratio (5yr expected):
--
EV / Free cash flow:
10.88x
Price / Operating cash flow:
6.70x
Enterprise value / EBITDA:
3.86x
Gross Profit (TTM):
$2.6B
Return On Assets:
1.21%
Net Income Margin (TTM):
2.66%
Return On Equity:
2.28%
Return On Invested Capital:
1.4%
Operating Margin:
19.07%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $11.1B $9.7B $8.9B $2.2B $2B
Gross Profit $3.8B $3.1B $2.6B $557M $538M
Operating Income $3B $2.4B $1.9B $399M $389M
EBITDA $4.6B $4.7B $4.2B $1B $941M
Diluted EPS $10.08 $7.54 $0.91 $1.92 $0.57
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1.3B $1.7B $1.6B $1.5B $1.2B
Total Assets $13.6B $14.4B $19.9B $19.9B $19.4B
Current Liabilities $3.4B $3.3B $3.5B $2.9B $2.6B
Total Liabilities $9.8B $7.8B $10.3B $9.2B $9.2B
Total Equity $3.8B $6.6B $9.6B $10.7B $10.2B
Total Debt $5.7B $4.5B $7B $6.7B $6.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $3.6B $4B $3.7B $1B $818.6M
Cash From Investing -$5.3B -$2.6B -$2.4B -$518.4M -$455.5M
Cash From Financing $1.7B -$1.3B -$1.3B -$452.1M -$362.1M
Free Cash Flow $1.2B $1.6B $1.5B $483.6M $269.8M
OVV
Sector
Market Cap
$9.6B
$36.2M
Price % of 52-Week High
82.03%
70.17%
Dividend Yield
3.16%
0%
Shareholder Yield
7.02%
0.05%
1-Year Price Total Return
-0.29%
-0.39%
Beta (5-Year)
0.775
0.453
Dividend yield:
3.16%
Annualized payout:
$1.20
Payout ratio:
52.32%
Growth streak:
4 years

Technicals

8-day SMA
Buy
Level $37.98
200-day SMA
Sell
Level $38.99
Bollinger Bands (100)
Sell
Level 37.74 - 41.54
Chaikin Money Flow
Buy
Level 20.1M
20-day SMA
Sell
Level $40.01
Relative Strength Index (RSI14)
Sell
Level 43.55
ADX Line
Sell
Level 21.04
Williams %R
Buy
Level -84.48
50-day SMA
Sell
Level $38.69
MACD (12, 26)
Sell
Level -0.47
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 185.9M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.5298)
Buy
CA Score (Annual)
Level (0.2765)
Buy
Beneish M-Score (Annual)
Level (-3.2254)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.9579)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Ovintiv, Inc. engages in the production and development of oil, natural gas liquids and natural gas producing plays. The firm operates through the following segments: Canadian Operations, USA Operations, and Market Optimization. The Canadian Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within Canada. The USA Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within the United States. The Market Optimization segment’s activities are managed by the Midstream, Marketing & Fundamentals team, which is responsible for the sale of the company’s proprietary production to third party customers. The company was founded in 1881 and is headquartered in Denver, CO.

Stock Forecast FAQ

In the current month, OVV has received 14 Buy ratings 3 Hold ratings, and 0 Sell ratings. The OVV average analyst price target in the past 3 months is $53.89.

  • Where Will Ovintiv, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Ovintiv, Inc. share price will rise to $53.89 per share over the next 12 months.

  • What Do Analysts Say About Ovintiv, Inc.?

    Analysts are divided on their view about Ovintiv, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ovintiv, Inc. is a Sell and believe this share price will drop from its current level to $42.00.

  • What Is Ovintiv, Inc.'s Price Target?

    The price target for Ovintiv, Inc. over the next 1-year time period is forecast to be $53.89 according to 17 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is OVV A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Ovintiv, Inc. is a Buy. 14 of 17 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of OVV?

    You can purchase shares of Ovintiv, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ovintiv, Inc. shares.

  • What Is The Ovintiv, Inc. Share Price Today?

    Ovintiv, Inc. was last trading at $38.05 per share. This represents the most recent stock quote for Ovintiv, Inc.. Yesterday, Ovintiv, Inc. closed at $38.05 per share.

  • How To Buy Ovintiv, Inc. Stock Online?

    In order to purchase Ovintiv, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock